Concomitant hyperfractionated accelerated radiotherapy (HART) with cisplatin and concurrent cetuximab for locoregionally advanced squamous cell head and neck cancer: a phase I dose escalation trial
Thomas Kuhnt(Leipzig University), Juergen Dunst(Martin Luther University Halle-Wittenberg), R. Engenhardt-Cabillic(Philipps University of Marburg), A. Pirnasch(University of Rostock), Thomas Wendt(Universität Trier), Michaël Baumann(Kantonsspital St. Gallen), Alexandra Sandner(Martin Luther University Halle-Wittenberg), Guido Lammering(Federal Highway and Transport Research Institute), Markus Flentje, Gerhard G. Grabenbauer(Klinikum Coburg)
Cited by 6
Related Papers
Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO/ARO/AIO-04 study): final results of the multicentre, open-label, randomised, phase 3 trial
|The Lancet Oncology|2015|723
Nomograms for Predicting Local Recurrence, Distant Metastases, and Overall Survival for Patients With Locally Advanced Rectal Cancer on the Basis of European Randomized Clinical Trials
|Journal of Clinical Oncology|2011|609
Randomized Phase II Trial of Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer: CAO/ARO/AIO-12
|Journal of Clinical Oncology|2019|550